Telix Pharmaceuticals Launches AU$600 Million Convertible Bond Offering to Fund Theranostic Portfolio, Pursue Potential M&As
Telix Pharmaceuticals Launches AU$600 Million Convertible Bond Offering to Fund Theranostic Portfolio, Pursue Potential M&As
Telix Pharmaceuticals推出了澳元6,000万可转债券型发行以为其治疗性产品线提供基金，并追求可能的药品相关并购。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册